20 (AIDX) Free Cash Flow (2025 - 2026)
20 (AIDX) posted Free Cash Flow of -$1.3 million for Q1 2026, down 163.97% on a QoQ basis from -$488293.0 in Q1 2025, and down 163.97% year-over-year from $2.0 million in Q1 2025.
20 (AIDX) Free Cash Flow (2025 - 2026) Analysis & Trends
20's Free Cash Flow history runs 2 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- Quarterly Free Cash Flow fell 163.97% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.8 million (changed N/A YoY) and the FY2025 annual result came in at -$1.9 million, up 27.75% from the prior year.
- Free Cash Flow was -$1.3 million for Q1 2026 at 20, down from -$488293.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at -$488293.0 in Q1 2025 and bottomed at -$1.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | 20 | 3.91 Mn | -313,912.28 | 62,884.00 | -1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2025 | -488,293.00 |
| Mar 31, 2025 | -488,293.00 |